Damle N K, Mohagheghpour N, Engleman E G
J Immunol. 1984 Sep;133(3):1235-40.
We showed previously that fresh Leu-2+ T cells respond to autologous antigen-primed Leu-3+ T cells by proliferation and differentiation into suppressor T cells (Ts) that specifically inhibit the response of fresh Leu-3+ cells to the original priming antigen. This study was undertaken to characterize the role of various cell surface molecules expressed by antigen-primed Leu-3+ cells in their activation of Leu-2+ Ts cells. Alloactivated Leu-3+ blasts were treated in the absence of complement with a variety of monoclonal antibodies recognizing distinct antigens on human lymphoid cells, and then were examined for their functional effects on fresh autologous T cells. Prior treatment of Leu-3+ blasts with anti-Leu-4 or anti-HLA-A,B,C framework antibodies, but not with anti-Leu-1, anti-Leu-3, anti-Leu-5, or anti-HLA-DR framework-specific antibodies, not only blocked proliferation of fresh Leu-2+ cells, it also prevented their differentiation into Ts cells. Furthermore, after their activation by Leu-3+ blasts, Leu-2+ Ts cells inhibited the response of fresh Leu-3+ cells from only those individuals who shared HLA-A,B phenotypes with suppressor-effector cells. These results suggest that both the inductive and effector phases of suppression involve dual recognition of autologous class I MHC molecules and structures associated with the Leu-4 (T3) molecule on the surface of antigen-reactive Leu-3+ cells.
我们之前曾表明,新鲜的Leu-2⁺ T细胞通过增殖并分化为抑制性T细胞(Ts)来对自身抗原致敏的Leu-3⁺ T细胞作出反应,这些抑制性T细胞能特异性抑制新鲜的Leu-3⁺细胞对原始致敏抗原的反应。本研究旨在表征抗原致敏的Leu-3⁺细胞表达的各种细胞表面分子在其激活Leu-2⁺ Ts细胞中的作用。用识别人类淋巴细胞上不同抗原的多种单克隆抗体在无补体的情况下处理同种异体激活的Leu-3⁺母细胞,然后检测它们对新鲜自体T细胞的功能影响。用抗Leu-4或抗HLA-A、B、C框架抗体而非抗Leu-1、抗Leu-3、抗Leu-5或抗HLA-DR框架特异性抗体预先处理Leu-3⁺母细胞,不仅会阻断新鲜Leu-2⁺细胞的增殖,还会阻止它们分化为Ts细胞。此外,Leu-2⁺ Ts细胞在被Leu-3⁺母细胞激活后,仅抑制那些与抑制效应细胞具有相同HLA-A、B表型的个体的新鲜Leu-3⁺细胞的反应。这些结果表明,抑制的诱导阶段和效应阶段都涉及对抗原反应性Leu-3⁺细胞表面自体I类MHC分子以及与Leu-4(T3)分子相关结构的双重识别。